# Comparison of Vortioxetine Versus Other Antidepressants With Pregabalin Augmentation in Burning Mouth Syndrome

> **NCT06025474** · PHASE3 · UNKNOWN · sponsor: **Federico II University** · enrollment: 203 (estimated)

## Conditions studied

- Burning Mouth Syndrome

## Interventions

- **DRUG:** Vortioxetine 20Mg Tab
- **DRUG:** Paroxetine 20 Mg Oral Tablet
- **DRUG:** Sertraline 50 MG
- **DRUG:** Citalopram 20mg
- **DRUG:** Escitalopram 10mg
- **DRUG:** Duloxetine 60 MG
- **DRUG:** Pregabalin 75mg

## Key facts

- **NCT ID:** NCT06025474
- **Lead sponsor:** Federico II University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-01
- **Primary completion:** 2023-10-30
- **Final completion:** 2024-07-24
- **Target enrollment:** 203 (ESTIMATED)
- **Last updated:** 2023-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06025474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06025474, "Comparison of Vortioxetine Versus Other Antidepressants With Pregabalin Augmentation in Burning Mouth Syndrome". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06025474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
